Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Cited by (772)

Items 101–200 of 772

1. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan
   Donghee Kim, Peter Konyn, George T. Cholankeril, Aijaz Ahmed · 2021 · Clinical Gastroenterology and Hepatology
2. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update
   Vasilios Gabriel Athyros, Κωνσταντίνος Τζιόμαλος, Niki Katsiki, Michael N. Doumas, Asterios I. Karagiannis, Dimitri P. Mikhailidis · 2015 · World Journal of Gastroenterology
3. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
   Ivana Mikolašević, Tajana Filipec-Kanižaj, Maja Mijić, Ivan Jakopčić, Sandra Milić, Irena Hrstić, Nikola Sobočan, Davor Štimac, Patrizia Burra · 2018 · World Journal of Gastroenterology
4. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
   Lonardo, Amedeo, Suzuki, Ayako · 2020 · Journal of Clinical Medicine
5. Lessons from Epidemiology: The Burden of Liver Disease
   Ian A.C. Rowe · 2017 · Digestive Diseases
6. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
   Uchenna A. Agbim, Sumeet K. Asrani · 2019 · Expert Review of Gastroenterology & Hepatology
7. Non-alcoholic fatty liver disease and cardiovascular risk
   Rashmee Patil, Gagan Sood · 2017 · World Journal of Gastrointestinal Pathophysiology
8. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
   Pierre Bédossa, Keyur Patel · 2016 · Gastroenterology
9. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
   Su Jong Yu, Won Kyum Kim, Donghee Kim, Jung‐Hwan Yoon, Kyoungbun Lee, Jung Ho Kim, Eun Ju Cho, Jeong‐Hoon Lee, Hwi Young Kim, Yoon Jun Kim et al. · 2015 · Medicine
10. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
    Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher · 2016 · World Journal of Gastroenterology
11. Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease
    Luis Calzadilla Bertot, Gary P. Jeffrey, Bastiaan de Boer, Gerry C. MacQuillan, George Garas, Justin Chin, Yi Huang, Leon Anton Adams · 2018 · Liver International
12. Recent Epidemiology of Nonalcoholic Fatty Liver Disease
    Soumya Murag, Aijaz Ahmed, Donghee Kim · 2020 · Gut and Liver
13. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
    Keating, Shelley E., Sabag, Angelo, Hallsworth, Kate, Hickman, Ingrid J., Macdonald, Graeme A., Stine, Jonathan G., George, Jacob, Johnson, Nathan A. · 2023 · Sports Medicine
14. The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care
    Pimsiri Sripongpun, W. Ray Kim, Ajitha Mannalithara, Vivek Charu, Anna A. Vidovszky, Steven M. Asch, Manisha Desai, Sun H. Kim, Allison J. Kwong · 2022 · Hepatology
15. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
    Min‐Sun Kwak, Donghee Kim · 2017 · The Korean Journal of Internal Medicine
16. Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
    Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Güallar, Juhee Cho et al. · 2019 · Journal of Gastroenterology and Hepatology
17. Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
    Sarah Shili‐Masmoudi, Grace Lai‐Hung Wong, Jean‐Baptiste Hiriart, Ken Liu, Faïza Chermak, Sally She‐Ting Shu, Juliette Foucher, Yee‐Kit Tse, Pierre–Henri Bernard, Terry Cheuk‐Fung Yip et al. · 2019 · Liver International
18. KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
    2013 · Clinical and Molecular Hepatology
19. Noninvasive Assessment of Liver Fibrosis
    Laurent Castéra, Mary E. Rinella, Emmanuel A. Tsochatzis · 2025 · New England Journal of Medicine
20. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis
    Zhu, Changyu, Tabas, Ira, Schwabe, Robert F., Pajvani, Utpal B. · 2021 · Nature Reviews Gastroenterology & Hepatology
21. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
    Michelle T. Long, Xiaoyu Zhang, Hanfei Xu, Ching‐Ti Liu, Kathleen E. Corey, Raymond T. Chung, Rohit Seth Loomba, Emelia J. Benjamin · 2020 · Hepatology
22. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
    Eugene Han, Yong‐ho Lee, Young Dae Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung‐Wan Lee, Eun Seok Kang, Bong Soo et al. · 2020 · The American Journal of Gastroenterology
23. Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
    Galit Weinstein, Kendra L. Davis‐Plourde, Jayandra Jung Himali, Shira Zelber‐Sagi, Alexa Beiser, Sudha S. Seshadri · 2019 · Liver International
24. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
    Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher · 2016 · Digestive Diseases and Sciences
25. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
    Andrew A. Li, Aijaz Ahmed, Donghee Kim · 2019 · Gut and Liver
26. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease
    Nandini M. Meyersohn, Thomas Mayrhofer, Kathleen E. Corey, Daniel O. Bittner, Pedro V. Staziaki, Bálint Szilveszter, Travis R. Hallett, Michael T. Lu, Stefan B. Puchner, Tracey G. Simon et al. · 2020 · Clinical Gastroenterology and Hepatology
27. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
    Zhenghui Gordon Jiang, Linda Feldbrügge, Elliot B. Tapper, Yury V. Popov, Tahereh Ghaziani, Nezam H. Afdhal, Simon Christopher Robson, Kenneth Jay Mukamal · 2016 · Alimentary Pharmacology & Therapeutics
28. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
    Lisa B. VanWagner, Mary Eugenia Rinella · 2016 · Current Hepatology Reports
29. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non‐alcoholic fatty liver disease
    Bo Kyung Koo, Sae Kyung Joo, Donghee Kim, Jeong Mo Bae, Jeong Hwan Park, Jung Ho Kim, Won Kyum Kim · 2017 · Journal of Gastroenterology and Hepatology
30. NAFLD in the Elderly
    Saleh A Alqahtani, Jörn Markus Schattenberg · 2021 · Clinical Interventions in Aging
31. Nonalcoholic fatty liver disease – current status and future directions
    Demir, Münevver, Lang, Sonja, Steffen, Hans‐Michael · 2015 · Journal of Digestive Diseases
32. Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
    Marco A. Arrese, Juan Pablo Arab, Francisco Barrera M., Benedikt K. Kaufmann, Luca V. C. Valenti, Ariel E. Feldstein · 2021 · Seminars in Liver Disease
33. Drugs and Targets in Fibrosis
    Xiaoyi Li, Lixin Zhu, Beibei Wang, Meifei Yuan, Ruixin Zhu · 2017 · Frontiers in Pharmacology
34. Depression is associated with non‐alcoholic fatty liver disease among adults in the United States
    Donghee Kim, Eric R. Yoo, Andrew A. Li, Sean P. Tighe, George T. Cholankeril, Stephen A. Harrison, Aijaz Ahmed · 2019 · Alimentary Pharmacology & Therapeutics
35. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
    Linge, Jennifer, Ekstedt, Mattias, Dahlqvist Leinhard, Olof · 2021 · JHEP Reports
36. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
    Elke Roeb, Ali E. Canbay, Frank Tacke, Heike Bantel, Jörg Bojunga, Jan de Laffolie, Münevver Demir, Ulrike Walburga Denzer, A Geier, Wolf Peter Hofmann et al. · 2022 · Zeitschrift für Gastroenterologie
37. Association of Liver Fibrosis With Cardiovascular Diseases in the General Population
    Mohammad Reza Ostovaneh, Bharath Ambale‐Venkatesh, Tomoki Fuji, Hooman Bakhshi, Ravi V. Shah, Venkatesh Locharla Murthy, Russell P. Tracy, Eliseo Güallar, Colin O. Wu, David A. Bluemke et al. · 2018 · Circulation Cardiovascular Imaging
38. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease
    Joana Vieira Barbosa, Scott C. Milligan, Andrew Frick, Jeremy Broestl, Zobair M. Younossi, Nezam H. Afdhal, Michelle Lai · 2022 · The American Journal of Gastroenterology
39. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
    Cristina Maria Muzica, Catalin Victor Sfarti, Anca Victorita Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Năstasă, Laura Huiban, Camelia Cojocariu, Ana-Maria Sîngeap, Irina Gîrleanu et al. · 2020 · Canadian Journal of Gastroenterology and Hepatology
40. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
    Peter Konyn, Aijaz Ahmed, Donghee Kim · 2022 · Clinical and Molecular Hepatology
41. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
    Mohammed Eslam, Aijaz Ahmed, Jean‐Pierre Després, Vivekanand Jha, Jason C. G. Halford, Jack Tan Wei Chieh, David C.H. Harris, Masaomi Nangaku, Stephen Colagiuri, Giovanni Targher et al. · 2021 · The Lancet. Gastroenterology & hepatology
42. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
    Xiaolin Liu, Qin Pan, Rui-Nan Zhang, Feng Shen, Shiyan Yan, Chao Sun, Zhengjie Xu, Yuanwen Chen, Jian‐Gao Fan · 2016 · World Journal of Gastroenterology
43. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population
    Aynur Ünalp–Arida, Constance E. Ruhl · 2015 · Hepatology
44. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease
    Da Gan, Lu Wang, Menghan Jia, Yuan Ru, Yiyun Ma, Weifang Zheng, Xueyin Zhao, Fei Yang, Tianru Wang, Yun Mu et al. · 2019 · Clinical Nutrition
45. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
    Rui Yu, Qiangwei Shi, Lei Liu, Lidong Chen · 2018 · BMC Gastroenterology
46. Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD
    Joana Vieira Barbosa, Scott C. Milligan, Andrew Frick, Jeremy Broestl, Zobair M. Younossi, Nezam H. Afdhal, Michelle Lai · 2021 · Hepatology Communications
47. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?
    Xiaolan Xu, Lushun Jiang, Chensi Wu, Liya Pan, Zhuoqi Lou, Chunting Peng, Yin Dong, Bing Ruan · 2021 · Journal of the Formosan Medical Association
48. Epidemiology of fatty liver: an update.
    Giorgio Bedogni, Valério Nobili, Claudio Tiribelli · 2014 · PubMed Central
49. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
    Stephen Franklin Weng, Joe Kai, Indra Neil Guha, Nadeem Qureshi · 2015 · Open Heart
50. Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
    David J. Kazierad, Kristin Chidsey, Veena R. Somayaji, Arthur J. Bergman, Morris J. Birnbaum, Roberto A. Calle · 2021 · Med
51. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies
    Kohei Oda, Hirofumi Uto, Seiichi Mawatari, Akio Ido · 2015 · Clinical Journal of Gastroenterology
52. Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease
    Lindsey S. Treviño, Tiffany A. Katz · 2017 · Endocrinology
53. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
    Daniele Pastori, Gregory Y.H. Lip, Alessio Farcomeni, Francesco Del Sole, Angela Sciacqua, Francesco Perticone, Rossella Marcucci, Elisa Grifoni, Pasquale Pignatelli, Francesco Violi et al. · 2018 · International Journal of Cardiology
54. NAFLD in the Elderly
    Saleh A. Alqahtani, Jörn Markus Schattenberg · 2021 · Dove Medical Press (Taylor and Francis Group)
55. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning
    Mazen Noureddin, Fady Y. Ntanios, Deepa Malhotra, Katherine Hoover, Birol Emir, Euan James McLeod, Naim Alkhouri · 2022 · Hepatology Communications
56. Prognostic Value of Controlled Attenuation Parameter by Transient Elastography
    Ken Liu, Vincent Wai‐Sun Wong, Keith Lau, Sienna Du Liu, Yee‐Kit Tse, Terry Cheuk‐Fung Yip, Raymond Kwok, Alex Yiu-Wa Chan, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong · 2017 · The American Journal of Gastroenterology
57. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver ⇑ , Asociación Latinoamericana para el Estudio del Hígado
    Laurent Castéra, Henry Lik‐Yuen Chan, Yuen Chan, Marco A. Arrese, Kwang‐Hyub Han · 2015
58. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
    Tracey G. Simon, Kathleen E. Corey, Christopher Paul Cannon, Michael A. Blazing, Jeong‐Gun Park, Michelle L. O’Donoghue, Raymond T. Chung, Robert Patrick Giugliano · 2018 · International Journal of Cardiology
59. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease
    Ying Chen, Min Xu, Tiange Wang, Jichao Sun, Wanwan Sun, Baihui Xu, Xiaolin Huang, Yu Xu, Jieli Lu, Xiaoying Li et al. · 2015 · Atherosclerosis
60. The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
    Salvatore Petta, Antonino Tuttolomondo, Cesare Gagliardo, Rita Zafonte, Giuseppe Brancatelli, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Luigi Galvano, Giuseppe La Tona et al. · 2016 · Medicine
61. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016
    Donghee Kim, Won Kyum Kim, Adeyinka Adejumo, George T. Cholankeril, Sean P. Tighe, Robert J. Wong, Stevan A. Gonzalez, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed · 2019 · Hepatology International
62. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
    Mark C.C. Cheah, Arthur J. McCullough, George Boon‐Bee Goh · 2017 · Journal of Clinical and Translational Hepatology
63. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease
    Qian Chen, Qing Li, Dan Li, Xuechen Chen, Zhaomin Liu, Gang Hu, Jingfeng Wang, Wenhua Ling · 2020 · Atherosclerosis
64. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
    Rajkumar Chinnadurai, James P. Ritchie, Darren Green, Philip A. Kalra · 2017 · Nephrology Dialysis Transplantation
65. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis
    Tracey G. Simon, Maria Esther Perez Trejo, Robyn L. McClelland, Ryan D. Bradley, Michael Joseph Blaha, Irfan Zeb, Kathleen E. Corey, Matthew Jay Budoff, Raymond T. Chung · 2018 · International Journal of Cardiology
66. Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
    Eugene Han, Yong‐ho Lee · 2017 · Diabetes & Metabolism Journal
67. Elevated serum ferritin is associated with increased mortality in non‐alcoholic fatty liver disease after 16 years of follow‐up
    Hannes Hagström, Patrik Nasr, Matteo Bottai, Mattias Ekstedt, Stergios Kechagias, Rolf W. Hultcrantz, Per I Stal · 2016 · Liver International
68. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality
    Donghee Kim, Luis Miguel Vazquez‐Montesino, Jessica A. Escober, Christopher T. Fernandes, George T. Cholankeril, Rohit Seth Loomba, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed · 2020 · The American Journal of Gastroenterology
69. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis
    Karn Wijarnpreecha, Susan M. Lou, Panadeekarn Panjawatanan, Wisit Cheungpasitporn, Surakit Pungpapong, Frank Lukens, Patompong Ungprasert · 2018 · Digestive and Liver Disease
70. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017
    Donghee Kim, Adeyinka Adejumo, Eric R. Yoo, Umair Iqbal, Andrew A. Li, Edward A. Pham, George T. Cholankeril, Jeffrey S. Glenn, Aijaz Ahmed · 2019 · Gastroenterology
71. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
    Dunya Tomic, William W. Kemp, Stuart Keith Roberts · 2018 · European Journal of Gastroenterology & Hepatology
72. Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha‐inhibitory dithiolethione in patients with non‐alcoholic fatty liver disease
    Won Kyum Kim, B. G. Kim, J. S. Lee, C. K. Lee, Jong Eun Yeon, M. S. Chang, J. H. Kim, H. Kim, S. Yi, J. Lee et al. · 2017 · Alimentary Pharmacology & Therapeutics
73. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population
    Min‐Sun Kwak · 2015 · World Journal of Gastroenterology
74. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes
    Yamini Natarajan, Jennifer R. Kramer, Xian Yu, Liang Li, Aaron P. Thrift, Hashem B. El‐Serag, Fasiha Kanwal · 2020 · Hepatology
75. Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis
    Bilal Hameed, Norah A. Terrault, Ryan M. Gill, Rohit Seth Loomba, Naga Chalasani, Jay H. Hoofnagle, Mark L. Van Natta, for the NASH CRN · 2018 · Alimentary Pharmacology & Therapeutics
76. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
    Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim · 2018 · Clinical and Molecular Hepatology
77. Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
    Łukasz Tanajewski, Rebecca Harris, David J Harman, Guruprasad Padur Aithal, Tim R Card, Georgios Gkountouras, Vladislav Berdunov, Indra Neil Guha, Rachel Ann Elliott · 2017 · BMJ Open
78. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men
    You‐Cheol Hwang, Hong Yup Ahn, Sung‐Woo Park, Cheol‐Young Park · 2017 · Clinical Gastroenterology and Hepatology
79. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA
    Karn Wijarnpreecha, Donghee Kim, Pascale Raymond, Melissa Scribani, Aijaz Ahmed · 2019 · European Journal of Gastroenterology & Hepatology
80. Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage
    Neal S. Parikh, Hooman Kamel, Babak Benjamin Navi, Costantino Iadecola, Alexander Eliot Merkler, Arun B. Jesudian, Jesse Dawson, Guido J. Falcone, Kevin Navin Sheth, David Jinou Roh et al. · 2020 · Stroke
81. Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population
    Yochai Schonmann, Hanny Yeshua, Itay Bentov, Shira Zelber‐Sagi · 2020 · Digestive and Liver Disease
82. FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
    Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono et al. · 2021 · Life
83. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
    Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuji Ogawa, Yuichiro Eguchi, Yoshio Sumida, Masashi Yoneda, Miwa Kawanaka, Satoru Saito, Katsutoshi Tokushige et al. · 2017 · Journal of Gastroenterology
84. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
    Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa et al. · 2021 · Journal of Gastroenterology and Hepatology
85. Current epidemiology of chronic liver disease
    Richie Manikat, Aijaz Ahmed, Donghee Kim · 2023 · Gastroenterology report
86. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
    James M. Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M. Younossi · 2018 · Liver International
87. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study
    Hyo Eun Park, Min‐Sun Kwak, Donghee Kim, Min-Kyung Kim, Myung‐Jin Cha, Su‐Yeon Choi · 2016 · The Journal of Clinical Endocrinology & Metabolism
88. Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States
    Donghee Kim, Karn Wijarnpreecha, Keeryth K. Sandhu, George T. Cholankeril, Aijaz Ahmed · 2021 · Liver International
89. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
    Joon Ho Moon, Won Kyum Kim, Bo Kyung Koo, Nam H. Cho · 2021 · Gut and Liver
90. Risk of cardiovascular disease and loss in life expectancy in NAFLD
    Ying Shang, Patrik Nasr, Linnea Widman, Hannes Hagström · 2022 · Hepatology
91. Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease
    Myoung Seok Lee, Jeong Mo Bae, Sae Kyung Joo, Hyunsik Woo, Dong Hyeon Lee, Yong Jin Jung, Byeong Gwan Kim, Kook Lae Lee, Won Kyum Kim · 2017 · PLoS ONE
92. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease
    Jing‐Lu Jin, Huiwen Zhang, Ye‐Xuan Cao, Huihui Liu, Qi Hua, Yanfang Li, Yan Zhang, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu et al. · 2021 · Hepatology International
93. Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018
    Donghee Kim, George T. Cholankeril, Rohit Seth Loomba, Aijaz Ahmed · 2020 · Clinical Gastroenterology and Hepatology
94. Relevance of low testosterone to nonalcoholic fatty liver disease
    Avni Mody, Donna L. White, Fasiha Kanwal, José M. Garcia · 2015 · Cardiovascular Endocrinology
95. Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle‐aged patients with non‐alcoholic fatty liver disease
    Toshifumi Tada, Hidenori Toyoda, Yasuhiro Sone, Satoshi Yasuda, Nozomi Miyake, Takashi Kumada, Junko Tanaka · 2019 · Journal of Gastroenterology and Hepatology
96. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
    Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q. Huang, Rohit Seth Loomba · 2022 · Hepatology Research
97. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
    Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo J. E. Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarık Kani, Wafaa Khannoussi, L. Lacaze et al. · 2022 · Clinical Nutrition
98. Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease
    Elliot B. Tapper, Katherine Maragaret Krajewski, Michelle Lai, Tracy L. Challies, R. Kane, Nezam H. Afdhal, Daryl Lau · 2014 · Gastroenterology report
99. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
    Kristina Rachel Chacko, John F. Reinus · 2016 · Clinics in Liver Disease
100. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease
     Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, Kathryn Effendi, Akinori Hashiguchi, Masanori Abe, Yasuharu Imai, Keisuke Hino, Shuhei Hige, Miwa Kawanaka et al. · 2017 · Hepatology Communications